Le Lézard
Classified in: Health
Subjects: NPT, PER

Rick Gordon Named Director of Inova Personalized Health Accelerator


FAIRFAX, Va., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The Inova Personalized Health Accelerator (IPHA) announced today that area investor and business strategist Rick Gordon has been appointed Director. He is a proven leader with more than 25 years of experience in providing organizations with strategic growth direction. Prior to joining Inova, Rick served as founding managing partner of MACH37, a market centric cybersecurity accelerator supported by a community of hundreds of industry leaders who contributed to company development. During his tenure at Mach37, Rick led investments in 46 disruptive technology companies.

Prior to this role, Rick served as Vice President of Product Management at KEYW Corporation, COO of Lookingglass Cyber Solutions, Inc., Managing Director at The Civitas Group,  CEO of Tovaris, and a technology investment banker at Bear, Stearns & Co. Rick served as a submarine officer in the U.S. Navy. He received his MBA from The Darden School at the University of Virginia and his BS in Engineering with Merit from the U.S. Naval Academy.

"We're thrilled to have Rick on the team," said Todd Stottlemyer, CEO of the Inova Center for Personalized Health (ICPH). "His combination of experience leading, mentoring, and investing in early stage companies makes him a perfect fit for our team."

IPHA, a variation on the traditional accelerator model, is differentiated by rolling admissions; with a limit of no more than 6 companies at one time and customized programs that provide individual companies the capital investment, mentoring, and networking they need to accelerate the development and commercialization of their products. The program also affords companies direct access to the Inova Health System to validate innovations and demonstrate value.

About Inova Personalized Health Accelerator 

The Inova Personalized Health Accelerator is a unique program that provides C-suite coaches, customized plans, early stage capital, connections to strategic partners and later stage capital, and connections to customers for healthcare technology and services entrepreneurs.  This bespoke approach to enhance med-tech entrepreneurs' efforts to accelerate new companies through the early stages of product design, capital formation and commercialization will serve as the foundation for a stronger healthcare ecosystem in the mid-Atlantic region. Additional program information is located at www.inovapha.org.

About Inova 

Inova is a global leader in personalized health, which leverages precision medicine to predict, prevent and treat disease, enabling individuals to live longer, healthier lives. At Inova, we serve more than 2 million people each year from throughout the Washington, DC, metro area and beyond.

We are shaping the future of health through our integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes.  Our commitment to health and wellness is further reflected in our sustainable practices. Inova is home to world-class researchers, expert medical specialists and renowned scientists, who are driving innovation to improve patient care, prevent disease and promote wellness. For more information, visit www.inova.org, or find Inova on FacebookTwitter and LinkedIn.

Kelly Schlageter 
[email protected] 
571-472-0200

 

SOURCE Inova Health System


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: